HEADER OXIDOREDUCTASE 05-FEB-14 4OPL TITLE CONSTRUCTING TAILORED ISOPRENOID PRODUCTS BY STRUCTURE-GUIDED TITLE 2 MODIFICATION OF GERANYLGERANYL REDUCTASE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CONSERVED ARCHAEAL PROTEIN; COMPND 3 CHAIN: A; COMPND 4 EC: 1.3.1.83; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SULFOLOBUS ACIDOCALDARIUS; SOURCE 3 ORGANISM_TAXID: 330779; SOURCE 4 STRAIN: ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770; SOURCE 5 GENE: SACI_0986; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ROSSMANN FOLD, OXIDOREDUCTASE, ARCHAEAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR R.P.MCANDREW,Y.KUNG,X.XIE,C.LIU,J.H.PEREIRA,J.D.KEASLING,P.D.ADAMS REVDAT 2 23-JUL-14 4OPL 1 JRNL REVDAT 1 09-JUL-14 4OPL 0 JRNL AUTH Y.KUNG,R.P.MCANDREW,X.XIE,C.C.LIU,J.H.PEREIRA,P.D.ADAMS, JRNL AUTH 2 J.D.KEASLING JRNL TITL CONSTRUCTING TAILORED ISOPRENOID PRODUCTS BY JRNL TITL 2 STRUCTURE-GUIDED MODIFICATION OF GERANYLGERANYL REDUCTASE. JRNL REF STRUCTURE V. 22 1028 2014 JRNL REFN ISSN 0969-2126 JRNL PMID 24954619 JRNL DOI 10.1016/J.STR.2014.05.007 REMARK 2 REMARK 2 RESOLUTION. 2.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: DEV_1616) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.51 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 61.2 REMARK 3 NUMBER OF REFLECTIONS : 14260 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.261 REMARK 3 R VALUE (WORKING SET) : 0.259 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 713 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.9909 - 5.0170 1.00 4277 219 0.1878 0.2360 REMARK 3 2 5.0170 - 3.9830 1.00 4289 224 0.2198 0.2462 REMARK 3 3 3.9830 - 3.4798 0.88 3789 198 0.2848 0.3452 REMARK 3 4 3.4798 - 3.1617 0.70 3025 150 0.3367 0.3285 REMARK 3 5 3.1617 - 2.9351 0.59 2484 132 0.3737 0.3583 REMARK 3 6 2.9351 - 2.7621 0.35 1534 81 0.3633 0.3616 REMARK 3 7 2.7621 - 2.6238 0.23 990 48 0.3653 0.4593 REMARK 3 8 2.6238 - 2.5100 0.16 677 34 0.3632 0.4303 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.080 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 3711 REMARK 3 ANGLE : 0.544 5017 REMARK 3 CHIRALITY : 0.021 531 REMARK 3 PLANARITY : 0.003 642 REMARK 3 DIHEDRAL : 10.824 1402 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: chain 'A' and (resid 1 through 79 ) REMARK 3 ORIGIN FOR THE GROUP (A): -21.3594 27.7956 -5.1434 REMARK 3 T TENSOR REMARK 3 T11: 1.1783 T22: 0.6101 REMARK 3 T33: 0.7421 T12: 0.4175 REMARK 3 T13: -0.5292 T23: -0.2301 REMARK 3 L TENSOR REMARK 3 L11: 2.4953 L22: 0.0468 REMARK 3 L33: 2.2200 L12: 0.3471 REMARK 3 L13: 0.1659 L23: 0.0600 REMARK 3 S TENSOR REMARK 3 S11: -0.6275 S12: -0.3288 S13: 0.8532 REMARK 3 S21: 0.1348 S22: 0.2522 S23: -0.0017 REMARK 3 S31: -0.6045 S32: -0.0754 S33: 0.4184 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: chain 'A' and (resid 80 through 340 ) REMARK 3 ORIGIN FOR THE GROUP (A): -14.1558 21.0660 -10.0118 REMARK 3 T TENSOR REMARK 3 T11: 0.7965 T22: 0.6443 REMARK 3 T33: 0.1550 T12: 0.0034 REMARK 3 T13: -0.3654 T23: 0.0726 REMARK 3 L TENSOR REMARK 3 L11: 3.5280 L22: 0.7464 REMARK 3 L33: 1.7657 L12: -0.3720 REMARK 3 L13: 1.1747 L23: -0.1059 REMARK 3 S TENSOR REMARK 3 S11: -0.8386 S12: 0.0216 S13: 0.9036 REMARK 3 S21: 0.0061 S22: 0.2725 S23: -0.0815 REMARK 3 S31: -1.0538 S32: 0.1390 S33: 0.2753 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: chain 'A' and (resid 341 through 452 ) REMARK 3 ORIGIN FOR THE GROUP (A): -19.6970 2.5620 -23.3460 REMARK 3 T TENSOR REMARK 3 T11: 0.3444 T22: 0.7276 REMARK 3 T33: 0.2702 T12: 0.0709 REMARK 3 T13: -0.0280 T23: -0.2120 REMARK 3 L TENSOR REMARK 3 L11: 3.2460 L22: 0.9573 REMARK 3 L33: 7.7816 L12: -0.1627 REMARK 3 L13: -1.0696 L23: 0.6480 REMARK 3 S TENSOR REMARK 3 S11: 0.0111 S12: 0.8603 S13: -0.6202 REMARK 3 S21: -0.1621 S22: -0.0697 S23: 0.2542 REMARK 3 S31: -0.0781 S32: -0.2986 S33: 0.1008 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4OPL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-FEB-14. REMARK 100 THE RCSB ID CODE IS RCSB084790. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-NOV-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111)AND REMARK 200 MULTILAYER REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19915 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.480 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 9.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.48 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.52 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX (PHENIX.PHASER: DEV_1525) REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS PH 7.5, 10% PEG 3350 AND REMARK 280 0.2 M L-PROLINE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.66550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.99850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.42000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.99850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.66550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.42000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 123 -74.47 -90.37 REMARK 500 ARG A 161 54.53 34.30 REMARK 500 ASP A 207 117.70 -168.06 REMARK 500 SER A 211 71.48 -162.44 REMARK 500 ALA A 253 74.18 -151.41 REMARK 500 LEU A 262 -62.80 -91.78 REMARK 500 TYR A 340 -25.20 -157.36 REMARK 500 ASN A 425 46.06 -98.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FDA A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4OPC RELATED DB: PDB REMARK 900 SAGGR BOUND TO PG REMARK 900 RELATED ID: 4OPD RELATED DB: PDB REMARK 900 SAGGR BOUND TO GGPP REMARK 900 RELATED ID: 4OPG RELATED DB: PDB REMARK 900 SAGGR L377H REMARK 900 RELATED ID: 4OPI RELATED DB: PDB REMARK 900 SAGGR F219L REMARK 900 RELATED ID: 4OPT RELATED DB: PDB REMARK 900 SAGGR I206F/L377H REMARK 900 RELATED ID: 4OPU RELATED DB: PDB DBREF 4OPL A 1 452 UNP Q4JA33 Q4JA33_SULAC 1 452 SEQADV 4OPL HIS A 0 UNP Q4JA33 EXPRESSION TAG SEQADV 4OPL PHE A 206 UNP Q4JA33 ILE 206 ENGINEERED MUTATION SEQRES 1 A 453 HIS MET LYS GLU LEU LYS TYR ASP VAL LEU ILE ILE GLY SEQRES 2 A 453 GLY GLY PHE ALA GLY SER SER ALA ALA TYR GLN LEU SER SEQRES 3 A 453 ARG ARG GLY LEU LYS ILE LEU LEU VAL ASP SER LYS PRO SEQRES 4 A 453 TRP ASN ARG ILE GLY ASP LYS PRO CYS GLY ASP ALA VAL SEQRES 5 A 453 SER LYS ALA HIS PHE ASP LYS LEU GLY MET PRO TYR PRO SEQRES 6 A 453 LYS GLY GLU GLU LEU GLU ASN LYS ILE ASN GLY ILE LYS SEQRES 7 A 453 LEU TYR SER PRO ASP MET GLN THR VAL TRP THR VAL ASN SEQRES 8 A 453 GLY GLU GLY PHE GLU LEU ASN ALA PRO LEU TYR ASN GLN SEQRES 9 A 453 ARG VAL LEU LYS GLU ALA GLN ASP ARG GLY VAL GLU ILE SEQRES 10 A 453 TRP ASP LEU THR THR ALA MET LYS PRO ILE PHE GLU ASP SEQRES 11 A 453 GLY TYR VAL LYS GLY ALA VAL LEU PHE ASN ARG ARG THR SEQRES 12 A 453 ASN GLU GLU LEU THR VAL TYR SER LYS VAL VAL VAL GLU SEQRES 13 A 453 ALA THR GLY TYR SER ARG SER PHE ARG SER LYS LEU PRO SEQRES 14 A 453 PRO GLU LEU PRO ILE THR GLU ASP LEU ASP ASP LYS ASP SEQRES 15 A 453 ALA ASP VAL ALA TYR ARG GLU VAL LEU LEU THR LYS GLU SEQRES 16 A 453 ASP ILE GLU ASP HIS ASP TYR LEU ARG ILE PHE PHE ASP SEQRES 17 A 453 GLN GLU THR SER PRO GLY GLY TYR TRP TRP TYR PHE PRO SEQRES 18 A 453 LYS GLY LYS ASN LYS VAL ASN VAL GLY LEU GLY ILE GLN SEQRES 19 A 453 GLY GLY MET GLY TYR PRO SER ILE HIS GLU TYR TYR LYS SEQRES 20 A 453 LYS TYR LEU ASP LYS TYR ALA PRO ASP VAL ASP LYS SER SEQRES 21 A 453 LYS LEU LEU VAL LYS GLY GLY ALA LEU VAL PRO THR ARG SEQRES 22 A 453 ARG PRO LEU TYR THR MET ALA TRP ASN GLY ILE ILE VAL SEQRES 23 A 453 ILE GLY ASP SER GLY PHE THR VAL ASN PRO VAL HIS GLY SEQRES 24 A 453 GLY GLY LYS GLY SER ALA MET ILE SER GLY TYR CYS ALA SEQRES 25 A 453 ALA LYS ALA ILE LEU SER ALA PHE GLU THR GLY ASP PHE SEQRES 26 A 453 SER ALA SER GLY LEU TRP ASP MET ASN ILE CYS TYR VAL SEQRES 27 A 453 ASN GLU TYR GLY ALA LYS GLN ALA SER LEU ASP ILE PHE SEQRES 28 A 453 ARG ARG PHE LEU GLN LYS LEU SER ASN ASP ASP ILE ASN SEQRES 29 A 453 TYR GLY MET LYS LYS LYS ILE ILE LYS GLU GLU ASP LEU SEQRES 30 A 453 LEU GLU ALA SER GLU LYS GLY ASP LEU HIS LEU SER VAL SEQRES 31 A 453 ALA ASP LYS ALA MET ARG VAL ILE SER GLY LEU GLY ARG SEQRES 32 A 453 PRO SER LEU LEU PHE LYS LEU LYS ALA VAL ALA GLU SER SEQRES 33 A 453 MET LYS LYS ILE LYS GLU LEU TYR LEU ASN TYR PRO ARG SEQRES 34 A 453 SER PRO SER SER LEU GLY SER TRP ARG ARG GLU VAL ASP SEQRES 35 A 453 ASN VAL LEU THR GLU PHE ASN LYS SER LEU SER HET FDA A 501 53 HETNAM FDA DIHYDROFLAVINE-ADENINE DINUCLEOTIDE FORMUL 2 FDA C27 H35 N9 O15 P2 FORMUL 3 HOH *8(H2 O) HELIX 1 1 GLY A 14 SER A 25 1 12 HELIX 2 2 PRO A 38 ILE A 42 5 5 HELIX 3 3 LYS A 53 LEU A 59 1 7 HELIX 4 4 LYS A 65 GLU A 67 5 3 HELIX 5 5 ASN A 97 ASP A 111 1 15 HELIX 6 6 THR A 157 ARG A 161 5 5 HELIX 7 7 PHE A 163 LEU A 167 5 5 HELIX 8 8 LEU A 171 GLU A 175 5 5 HELIX 9 9 ASP A 178 LYS A 180 5 3 HELIX 10 10 SER A 240 ALA A 253 1 14 HELIX 11 11 GLY A 287 PHE A 291 5 5 HELIX 12 12 GLY A 300 GLU A 320 1 21 HELIX 13 13 TRP A 330 TYR A 340 1 11 HELIX 14 14 TYR A 340 GLN A 355 1 16 HELIX 15 15 SER A 358 LYS A 368 1 11 HELIX 16 16 LYS A 372 GLU A 381 1 10 HELIX 17 17 HIS A 386 SER A 398 1 13 HELIX 18 18 SER A 404 PHE A 407 5 4 HELIX 19 19 LYS A 408 ASN A 425 1 18 HELIX 20 20 SER A 429 SER A 431 5 3 HELIX 21 21 SER A 432 LEU A 451 1 20 SHEET 1 A 6 GLU A 115 ASP A 118 0 SHEET 2 A 6 ILE A 31 ASP A 35 1 N LEU A 33 O TRP A 117 SHEET 3 A 6 GLU A 3 ILE A 11 1 N ILE A 10 O LEU A 32 SHEET 4 A 6 GLU A 144 GLU A 155 1 O VAL A 154 N LEU A 9 SHEET 5 A 6 TYR A 131 ASN A 139 -1 N ALA A 135 O VAL A 148 SHEET 6 A 6 THR A 120 GLU A 128 -1 N LYS A 124 O VAL A 136 SHEET 1 B 6 GLU A 115 ASP A 118 0 SHEET 2 B 6 ILE A 31 ASP A 35 1 N LEU A 33 O TRP A 117 SHEET 3 B 6 GLU A 3 ILE A 11 1 N ILE A 10 O LEU A 32 SHEET 4 B 6 GLU A 144 GLU A 155 1 O VAL A 154 N LEU A 9 SHEET 5 B 6 ILE A 283 VAL A 285 1 O ILE A 284 N GLU A 155 SHEET 6 B 6 ALA A 279 TRP A 280 -1 N TRP A 280 O ILE A 283 SHEET 1 C 8 ALA A 50 SER A 52 0 SHEET 2 C 8 VAL A 86 LEU A 96 -1 O PHE A 94 N VAL A 51 SHEET 3 C 8 LEU A 69 TYR A 79 -1 N ILE A 76 O VAL A 89 SHEET 4 C 8 TYR A 201 PHE A 205 1 O LEU A 202 N LYS A 77 SHEET 5 C 8 TYR A 215 PRO A 220 -1 O TRP A 216 N PHE A 205 SHEET 6 C 8 LYS A 225 GLN A 233 -1 O ASN A 227 N PHE A 219 SHEET 7 C 8 ALA A 182 THR A 192 -1 N VAL A 184 O ILE A 232 SHEET 8 C 8 VAL A 256 PRO A 270 -1 O VAL A 269 N ASP A 183 SSBOND 1 CYS A 310 CYS A 335 1555 1555 2.03 SITE 1 AC1 29 ILE A 11 GLY A 12 GLY A 14 PHE A 15 SITE 2 AC1 29 ALA A 16 ASP A 35 SER A 36 LYS A 37 SITE 3 AC1 29 LYS A 45 PRO A 46 CYS A 47 GLY A 48 SITE 4 AC1 29 ASP A 49 ALA A 50 THR A 120 ALA A 122 SITE 5 AC1 29 ALA A 156 THR A 157 GLY A 158 SER A 162 SITE 6 AC1 29 ALA A 185 ALA A 267 VAL A 269 GLY A 287 SITE 7 AC1 29 ASP A 288 VAL A 293 GLY A 299 GLY A 300 SITE 8 AC1 29 LYS A 301 CRYST1 65.331 78.840 105.997 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015307 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012684 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009434 0.00000